Terumo (OTCMKTS:TRUMY) Shares Gap Up – Here’s Why

Terumo Corp. (OTCMKTS:TRUMY) gapped up before the market opened on Tuesday . The stock had previously closed at $13.25, but opened at $13.9601. Terumo shares last traded at $13.98, with a volume of 39,095 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised shares of Terumo to a “hold” rating in a report on Thursday, April 9th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock has an average rating of “Hold”.

Terumo Price Performance

The stock’s fifty day moving average is $14.01 and its 200-day moving average is $13.53. The stock has a market capitalization of $21.90 billion, a PE ratio of 24.34 and a beta of 0.68. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.59 and a quick ratio of 0.97.

Terumo (OTCMKTS:TRUMY) last released its quarterly earnings results on Friday, May 15th. The company reported $0.11 EPS for the quarter, meeting the consensus estimate of $0.11. The company had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.84 billion. Terumo had a net margin of 12.09% and a return on equity of 9.17%. As a group, equities analysts predict that Terumo Corp. will post 0.7 earnings per share for the current fiscal year.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.